PETACH TIKVA, Israel – (BUSINESS WIRE) Erectile dysfunction market is estimated to reach $3.2 billion by 2022 Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline…
Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the “Company” or “Kalytera”) today announced that it will meet with the Center for Drug Evaluation and Research (“CDER”) of the U.S. Food and…
Study fully funded by BARDA YAVNE, Israel, June 19, 2018 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced…
Galil Ofek is proud to welcome our new partners – Mor Research Applications. Mor Research Applications is the Technology Transfer Office of Clalit Health Services, the largest HMO in Israel, Mor’s…
NEW YORK, Feb. 16, 2018 (GLOBE NEWSWIRE) — AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with serious…
AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with serious lung infections, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company for its novel NO formulation for the treatment of infections caused by NTM.
Zebra Medical Vision, the leading machine learning imaging analytics company, announces that the company has been granted the CE approval and subsequent release of its Deep Learning Analytics Engine in Europe, as well as regulatory clearance and product release in Australia and New Zealand.
Lead program in Graft versus Host Disease (“GvHD”), a life-threatening condition that can occur following stem cell or bone marrow transplantation Four Phase 2 clinical studies evaluating CBD in the…
August 14, 2016 Israeli company EyeYon Medical, has received US marketing authorization for its medical contact lens for the treatment of corneal edema. The product is already approved for marketing…